Pharmacovigilance and Adverse Drug Reactions

What is the promising application of genomic developments in clinical pharmacology?

What is the estimated proportion of drug-related injuries that could be prevented?

What is the significance of phenotyping and genotyping in clinical pharmacology?

What is the focus of pharmacoepidemiology in clinical pharmacology?

What is the term for the study of the pathogenesis of diseases?

What is the significance of understanding genetic influences on drug pharmacokinetics and pharmacodynamics?

What is the purpose of predictive tests in clinical pharmacology?

What is the term for the study of the detection and classification of adverse drug reactions?

What is the focus of clinical pharmacology in diseases?

What is the significance of knowledge of the human genome in clinical pharmacology?

WHO Monitoring Programme

The WHO monitoring programme is based in Uppsala and supports the European Pharmacovigilance Research Group.
The programme plans to extend the use of Bayesian artificial neural networks for analyzing large amounts of data to detect hidden risk factors for drug-related ailments.
Improvements are also planned for classification systems of traditional herbal remedies and communication in pharmacovigilance.

Pharmacovigilance Methods

Methods for detecting adverse drug reactions include anecdotal reporting, voluntary organized reporting, intensive event monitoring, cohort studies, case-control studies, case-cohort studies, population statistics, and record linkage.
Each method has its advantages and disadvantages.

Future Developments

Clinical pharmacology has a promising future with possibilities of interfering with disease processes at basic and specific levels.
Knowledge of the human genome will allow prediction of susceptibility to diseases and better understanding of drug-induced disease.
Genomic developments will enable predictive tests for drug actions, including adverse drug reactions, allowing for more accurate tailoring of therapy.

Importance of Pharmacovigilance

About half of drug-related injuries are due to potentially avoidable adverse drug reactions.
It is essential to continue improving pharmacovigilance to reduce drug-related harm.

This quiz covers the monitoring and prevention of adverse drug reactions, as well as the initiatives and programmes in place to ensure drug safety. Learn about the WHO monitoring programme and the European Pharmacovigilance Research Group. Test your knowledge on pharmacovigilance and its importance in the medical field.